ABBV241122P225000
- 24.70
- 0.000.00%
AbbVie Newsroom
Spotlight on AbbVie: Analyzing the Surge in Options Activity
Catalyst Watch: November Jobs, OPEC+ Meeting, Marvell, Salesforce Earnings
Why Is AbbVie (ABBV) Down 10.2% Since Last Earnings Report?
With 73% Ownership in AbbVie Inc. (NYSE:ABBV), Institutional Investors Have a Lot Riding on the Business
Why AbbVie Inc. (ABBV) Is One of the Most Undervalued Pot Stocks to Buy?
Wednesday Ends With Index Decline | Wall Street Today
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Unusual Options Activity: EDR, BBD and Others Attract Market Bets, EDR V/OI Ratio Reaches 174.3
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Alector/AbbVie-Partnered Alzheimer's Drug Disappoints In Mid-Stage Study; Alector Lays Off 17% Of Workforce
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
(ABBV) - Analyzing AbbVie's Short Interest
Is AbbVie Inc. (ABBV) the Best Dividend Aristocrat Stock To Buy Right Now?
JPMorgan Updates Its U.S. Analyst Focus List – Adds TPR, ALRM, REG
Market Whales and Their Recent Bets on ABBV Options
S&P 500, Dow Hit Records Right After Open | Live Stock
Capsida Biotherapeutics to Present at 7th Annual Evercore HealthCONx Conference
AbbVie to Present at Citi's 2024 Global Healthcare Conference
Are Hedge Funds Betting Big On AbbVie Inc. (ABBV)?
AbbVie Gains on Leerink Partners Upgrade to Outperform